×
RAPS Learning Portal will be under maintenance on 12 June 2026 between 10 PM - 12 AM ET. Learning Portal functionality and profile access may be unavailable during this window.
We apologize for any inconvenience caused during this time.
  1. You are here:
  2. Homepage
  3. News & Insights Search
  4. India Pharma Reps Protest Corruption, Drug Prices

rf-fullcolor.png

 

Regulatory News
28 August 2012
by RAPS

India Pharma Reps Protest Corruption, Drug Prices

Pharmaceutical sales representatives in India went on strike to protest treatment of the reps, increasing drug prices and corporate corruption in their industry, according to PMLive.

The one-day strike was held on 23 August and organized by the Federation of Medical and Sales Representatives Associations of India (FMRAI). The group's newsletter said widespread corruption is creating attacks on the job security of sales reps, including an increase in reps being banned from hospitals and medical institutions.

The PMLive report said FMRAI wants a cap on medicine prices, a code of ethics for sales and marketing practices, and action against pharma corporate corruption.

A GlobalData report said the pharma market in India could reach as high as $54billion by 2020.

Read more 


Return to listing